Dr. James Page has been a director since 1996. He retired in 1991 as Vice President with Adria Laboratories, Inc., a pharmaceutical company that specializes in developing therapy for cancer and AIDS. Prior to that, he held various senior management positions with Carter Wallace, Inc., Merck Sharpe & Dohme Research Laboratories and Wyeth Laboratories.

Dr. Stephen Chen has been a director since February 1996. He is currently President and Chief Executive Officer of STC International, Inc., a health care investment firm. Prior to that Dr. Chen was a Director of Pharmaceutical Research and Development at Ciba-Geigy.

Dr. Dennis Moore has been a director since 1986. Dr. Moore developed a veterinary practice and laboratory in California. He currently manages his investments and operates a Montana ranch.

Mr. Thomas D’Alonzo, JD, is a seasoned executive with experience in all major facets of pharmaceutical operations: sales and marketing, manufacturing, quality assurance, finance and licensing and strategic planning.  Mr. D’Alonzo served as President of Pharmaceutical Product Development, Inc., a multi-national clinical research organization with 3,000 employees operating in 14 countries and generating $300 million in revenues from analytical labs and Phase 1, 2, 3 and 4 clinical trials.  Previously, Mr. D’Alonzo was President of Genevec, Inc., a gene therapy biotech company. Before that, Mr. D’Alonzo was President of Glaxo, Inc., the US unit of what is now Glaxo SmithKline.